162 related articles for article (PubMed ID: 1668860)
21. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
Ferrini S; Miescher S; Zocchi MR; von Fliedner V; Moretta A
J Immunol; 1987 Feb; 138(4):1297-302. PubMed ID: 3100633
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid.
Rogers CE; Bradley MS; Palsson BO; Koller MR
Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964
[TBL] [Abstract][Full Text] [Related]
23. Leukocyte subpopulations and natural killer activity in endometriosis.
Iwasaki K; Makino T; Maruyama T; Matsubayashi H; Nozawa S; Yokokura T
Int J Fertil Menopausal Stud; 1993; 38(4):229-34. PubMed ID: 8401682
[TBL] [Abstract][Full Text] [Related]
24. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
25. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
26. Stable expression of EBV-gp350 on the surface of NC37 cells confers natural killer (NK)-cell susceptibility or resistance, depending on the assay used to assess NK-mediated function.
Sumonwiriya M; Horhthongkham N; Pattanapanyasat K; Ampol S; Sutthent R; Kantakamalakul W
J Virol Methods; 2009 Oct; 161(1):154-60. PubMed ID: 19539652
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays.
Cholujová D; Jakubíková J; Kubes M; Arendacká B; Sapák M; Ihnatko R; Sedlák J
Immunobiology; 2008; 213(8):629-40. PubMed ID: 18765168
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric immunophenotyping of lymphocyte subsets in samples that contain a high proportion of non-lymphoid cells.
Pattanapanyasat K; Kyle DE; Tongtawe P; Yongvanitchit K; Fucharoen S
Cytometry; 1994 Dec; 18(4):199-208. PubMed ID: 7534676
[TBL] [Abstract][Full Text] [Related]
29. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
30. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
31. Resistance against natural killer cell cytotoxicity: analysis of mechanisms.
Hasenkamp J; Borgerding A; Wulf G; Uhrberg M; Jung W; Dingeldein S; Truemper L; Glass B
Scand J Immunol; 2006 Oct; 64(4):444-9. PubMed ID: 16970688
[TBL] [Abstract][Full Text] [Related]
32. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
Roozemond RC; Bonavida B
J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
35. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
[TBL] [Abstract][Full Text] [Related]
36. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
Zhang X; Wei H; Wang H; Tian Z
Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
[TBL] [Abstract][Full Text] [Related]
37. Screening of high cytotoxic tumor killer cells using a sensitive adherent target detachment assay.
Wang X; Cai J; Zhong H; Denham SA; Terasaki PI
J Immunol Methods; 2004 Dec; 295(1-2):57-65. PubMed ID: 15627611
[TBL] [Abstract][Full Text] [Related]
38. Expression and function of CD7 molecule on human natural killer cells.
Rabinowich H; Pricop L; Herberman RB; Whiteside TL
J Immunol; 1994 Jan; 152(2):517-26. PubMed ID: 7506726
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinV/propidium iodide colabeling by fluorosphere-adjusted counts on three-color flow cytometry.
Ozdemir O; Ravindranath Y; Savaşan S
Cytometry A; 2003 Nov; 56(1):53-60. PubMed ID: 14566939
[TBL] [Abstract][Full Text] [Related]
40. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
Uchida A; Yanagawa E
J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
